ReviewFrontiers in oncology2015

Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer.

Sven Mahner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.